Gerich, John E.

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine

Metabolism, Diabetes, and CancerDiabetes Treatment and Management

Cited by 1,148

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Zinman, B., Gerich, J., Buse, J. B., Lewin, A., Schwartz, S., Raskin, P., Hale, P. M., Zdravkovic, M., Blonde, L., & the LEAD-4 Study Investigators (2009) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 848

Cortisol-Induced Insulin Resistance in Man: Impaired Suppression of Glucose Production and Stimulation of Glucose Utilization due to a Postreceptor Defect of Insulin Action*

RIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism

Pancreatic function and diabetesAdrenal Hormones and Disorders

Cited by 696

Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect

Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 688

Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance

Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992) · New England Journal of Medicine

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 595

Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction

Mitrakou, A., Ryan, C., Veneman, T., Mokan, M., Jenssen, T., Kiss, I., Durrant, J., Cryer, P., & Gerich, J. (1991) · American Journal of Physiology-Endocrinology and Metabolism

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 558

Effects of Growth Hormone on Insulin Action in Man: Mechanisms of Insulin Resistance, Impaired Suppression of Glucose Production, and Impaired Stimulation of Glucose Utilization

Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1982) · Diabetes

Growth Hormone and Insulin-like Growth FactorsPancreatic function and diabetes

Cited by 440

Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion

Bolli, G., Feo, P. D., Compagnucci, P., Cartechini, M. G., Angeletti, G., Santeusanio, F., Brunetti, P., & Gerich, J. E. (1983) · Diabetes

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 433

Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation

Rizza, R. A., Cryer, P. E., & Gerich, J. E. (1979) · Journal of Clinical Investigation

Pancreatic function and diabetesDiabetes Management and Research

Cited by 421

Effects of glucocorticoids on carbohydrate metabolism

Mcmahon, M., Gerich, J., & Rizza, R. (1988) · Diabetes/Metabolism Reviews

Adrenal Hormones and DisordersDiabetes Treatment and Management

Cited by 390

The role of α-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications

Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 369

Adrenergic Mechanisms for the Effects of Epinephrine on Glucose Production and Clearance in Man

Rizza, R. A., Cryer, P. E., Haymond, M. W., & Gerich, J. E. (1980) · Journal of Clinical Investigation

Pancreatic function and diabetesDiabetes Management and Research

Cited by 340

Regulation of Pancreatic Insulin and Glucagon Secretion

Gerich, J. E., Charles, M. A., & Grodsky, G. M. (1976) · Annual Review of Physiology

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 332

Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia

Gerich, J. E. (2003) · Archives of Internal Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 321

Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM

Mitrakou, A., Kelley, D., Veneman, T., Jenssen, T., Pangburn, T., Reilly, J., & Gerich, J. (1990) · Diabetes

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 317

Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes

Woerle, H. J., Neumann, C., Zschau, S., Tenner, S., Irsigler, A., Schirra, J., Gerich, J. E., & Göke, B. (2007) · Diabetes Research and Clinical Practice

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 316

Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans

Meyer, C., Pimenta, W., Woerle, H. J., Van Haeften, T., Szoke, E., Mitrakou, A., & Gerich, J. (2006) · Diabetes Care

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 308

Carbohydrate Metabolism in Non-Insulin-Dependent Diabetes Mellitus

Dinneen, S., Gerich, J., & Rizza, R. (1992) · New England Journal of Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 279

Control of Blood Sugar in Insulin-Dependent Diabetes: Comparison of an Artificial Endocrine Pancreas, Continuous Subcutaneous Insulin Infusion, and Intensified Conventional Insulin Therapy

Rizza, R. A., Gerich, J. E., Haymond, M. W., Westland, R. E., Hall, L. D., Clemens, A. H., & Service, F. J. (1980) · New England Journal of Medicine

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 279

Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus

Epstein, F. H., Cryer, P. E., & Gerich, J. E. (1985) · New England Journal of Medicine

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 273

Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis

Meyer, C., Dostou, J. M., Welle, S. L., & Gerich, J. E. (2002) · American Journal of Physiology-Endocrinology and Metabolism

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 269

Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?

Gerich, J. E. (2002) · Diabetes

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 264

Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin

Rosenstock, J., Raccah, D., Korányi, L., Maffei, L., Boka, G., Miossec, P., & Gerich, J. E. (2013) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 253

The “Dawn-Phenomenon” – a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus

Bolli, G. B., & Gerich, J. E. (1984) · New England Journal of Medicine

Diabetes Management and ResearchPancreatic function and diabetes

Cited by 235